Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Orphazyme A/S ADR (NQ: ORPH )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Orphazyme A/S ADR

Promising New Developments Causing Some Biotech Stocks to Pull Away from Underperforming Peers
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 14, 2021 – USA News Group – Compared to the Dow Jones Industrial Average which has gained an impressive 10.6% through Q3... 
Via FinancialNewsMedia
Topics Stocks
Exposures US Equities
Orphazyme A/S (NASDAQ:ORPH) Shareholder Notice: Deadline in Lawsuit on September 7, 2021
San Diego, CA -- (SBWIRE) -- 10/06/2021 -- The Shareholders Foundation announced that a deadline is coming up on September 7, 2021 in the lawsuit filed for certain investors of Orphazyme A/S... 
Via SBWire
Topics Lawsuit
Exposures Financial Legal Product Safety
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Final Deadline for Investors with Losses Exceeding $500K to Actively Participate in the Orphazyme A/S (ORPH) Class Action - Bronstein, Gewirtz & Grossman, LLC
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)
From The Law Offices of Frank R. Cruz
Via Business Wire
TUESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
TUESDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
NASDAQ:ORPH Investor Notice: Deadline on September 7, 2021 in Lawsuit Against Orphazyme A/S
San Diego, CA -- (SBWIRE) -- 08/26/2021 -- The Shareholders Foundation announced that a deadline is coming up on September 7, 2021 in the lawsuit filed for certain investors of Orphazyme A/S... 
Via SBWire
Topics Lawsuit
Exposures Financial Legal Product Safety
CytRx Highlights Orphazyme’s Published Results From Its Phase 2/3 Trial of Arimoclomol in Niemann-Pick Disease Type C
From CytRx Corporation
Via Business Wire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orphazyme A/S Investors With Losses Exceeding $100K to Secure Counsel Before Important September 7 Deadline in Securities Class Action – ORPH
From The Rosen Law Firm, P.A.
Via Business Wire
NASDAQ: ORPH Investor Notice: Lawsuit Alleges Securities Laws Violations by Orphazyme A/S
San Diego, CA -- (SBWIRE) -- 07/28/2021 -- A lawsuit was filed on behalf of investors in Orphazyme A/S (NASDAQ: ORPH) shares over alleged securities laws violations. 
Via SBWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)
From Law Offices of Howard G. Smith
Via Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Orphazyme A/S (ORPH)
From Glancy Prongay & Murray LLP
Via Business Wire
ORPH Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Orphazyme A/S Shareholders of Class Action and Encourages Shareholders to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orphazyme A/S Investors With Losses to Secure Counsel Before Important September 7 Deadline in Securities Class Action – ORPH
From The Rosen Law Firm, P.A.
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Orphazyme A/S (ORPH) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Orphazyme A/S (ORPH) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Orphazyme A/S (ORPH) Investors
From Law Offices of Howard G. Smith
Via Business Wire
SHAREHOLDER ALERT: Robbins LLP Announces that Orphazyme A/S (ORPH) is Being Sued for Misleading Shareholders
From Robbins LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Orphazyme A/S (ORPH) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Orphazyme A/S (ORPH) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Orphazyme A/S (ORPH) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Orphazyme A/S Investors with Losses to Secure Counsel Before Important Deadline – ORPH
From The Rosen Law Firm, P.A.
Via Business Wire
ORPHAZYME ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Orphazyme A/S and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ORPHAZYME INVESTOR ALERT: Investors With Substantial Losses Have Opportunity to Lead the Orpahzyme A/S Class Action Lawsuit - ORPH
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.